5198 Federal Register / Vol. 70, No. 20 / Tuesday, February 1, 2005 / Notices 

Place: Sheraton Cresent Hotel, 2620 West 

Dunlap Avenue, Phoenix, AZ 85021.

Contact Person: Najma Begum, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2175, 

MSC 7818, Bethesda, MD 20892, 301–435–

1243, begumn@csr.nih.gov.

Name of Committee: Oncological Sciences 

Integrated Review Group, Tumor Cell Biology 

Study Section. 

Date: February 27–March 1, 2005. 

Time: 6:30 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Angela Y. Ng, PhD, MBA, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6200, 

MSC 7804, (For courier delivery, use MD 

20817), Bethesda, MD 20892, 301–435–1715, 

nga@csr.nih.gov.

Name of Committee: Oncological Sciences 

Integrated Review Group, Tumor 

Microenvironment Study Section. 

Date: February 28–March 1, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Eun Ah Cho, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, 301–435–

4467, choe@csr.nih.gov.

Name of Committee: Oncological Sciences 

Integrated Review Group, Cancer Genetics 

Study Section. 

Date: February 28–March 1, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Zhiqiang Zou, PhD, MD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6190, 

MSC 7804, Bethesda, MD 20892, 301–451–

0132, zouzhiq@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, SSMI 10: 

Small Business Bioengineering and 

Physiology. 

Date: February 28–March 1, 2005. 

Time: 8 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Bethesda North Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Pushpa Tandon, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5104, 

MSC 7854, Bethesda, MD 20892, 301–435–

2397, tandonp@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Neural 

Prosthesis Bioengineering Research 

Partnerships (PAR 04–023). 

Date: February 28, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814.

Contact Person: Jean D. Sipe, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4106, 

MSC 7814, Bethesda, MD 20892, 301–435–

1743, sipej@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Computation Biophysics. 

Date: February 28, 2005. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW., Washington, DC 20036. 

Contact Person: George W. Chacko, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4186, 

MSC 7849, Bethesda, MD 20892, 301–435–

1220, chackoge@csr.nih.gov.

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated Review 

Group, Clinical Neuroplasticity and 

Neurotransmitters Study Section. 

Date: February 28–March 1, 2005. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Ave., NW., Washington, DC 20037. 

Contact Person: William C. Benzing, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5206, 

MSC 7846, Bethesda, MD 20892, 301–435–

1254, benzingw@csr.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS)

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 05–1821 Filed 1–31–05; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C.. appendix 2), notice 

is hereby given of the following 

meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: Immunology 

Integrated Review Group, Cellular and 

Molecular Immunology—A. 

Date: February 17–18, 2005. 

Time: 8:30 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Beacon Hotel and Corporate 

Quarters, 1615 Rhode Island Avenue, NW., 

Washington, DC 20036. 

Contact Person: Samuel C. Edwards, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4200, 

MSC 7812, Bethesda, MD 20892, 301–435–

1152, edwardss@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Urologyrelated Science. 

Date: February 18, 2005. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: M. Chris Langub, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4112, 

MSC 7814, Bethesda, MD 20892, 301–496–

8551, langubm@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Innate 

Immunity and Inflammation. 

Date: February 24–25, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Select, 480 King Street, 

Alexandria, VA 22314. 

Contact Person: Tina McIntyre, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4202, 

MSC 7812, Bethesda, MD 20892, 301–594–

6375, mcintyrt@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Prokaryotic 

and Eukaryotic Genetics and Molecular 

Biology. 

Date: February 24–25, 2005. 

Time: 8:30 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Four Points by Sheraton Bethesda, 

8400 Wisconsin Avenue, Bethesda, MD 

20814. 

Contact Person: Mary P. McCormick, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2208, 

MSC 7890, Bethesda, MD 20892, 301–435–

1047, mccormim@csr.nih.gov.

Federal Register / Vol. 70, No. 20 / Tuesday, February 1, 2005 / Notices 5199

Name of Committee: Cardiovascular 

Sciences Integrated Review Group; Cardiac 

Contractility, Hypertrophy, and Failure 

Study Section. 

Date: February 28–March 1, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Select, 8120 Wisconsin 

Ave, Bethesda, MD 20814

Contact Person: Russell T. Dowell, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4128, 

MSC 7814, Bethesda, MD 20892, 301–435–

1850, dowellr@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Biomaterials 

and Biointerfaces: Quorum. 

Date: February 28–March 1, 2005. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Select Bethesda, 8120 

Wisconsin Ave, Bethesda, MD 20814. 

Contact Person: Alexander Gubin, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4196, 

MSC 7812, Bethesda, MD 20892, 301–435–

2902, gubina@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Bacterial 

Pathogenesis. 

Date: February 28, 2005. 

Time: 10:30 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Marian Wachtel, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3208, 

MSC 7858, Bethesda, MD 20892, 301–435–

1148, wachtelm@csr.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS)

Dated: January 26, 2005. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 05–1841 Filed 1–31–05; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HOMELAND 

SECURITY 

Bureau of Customs and Border 

Protection 

Automated Commercial Environment 

(ACE): Elimination of C–TPAT 

Requirement To Establish ACE 

Importer and Broker Accounts

AGENCY: Customs and Border Protection; 

Department of Homeland Security.

ACTION: General notice.

SUMMARY: This notice announces a 

change to the application requirements 

when applying to become an Importer 

or Broker Account so as to access the 

Automated Commercial Environment 

(ACE) Secure Data Portal (‘‘ACE Portal’’) 

or to participate in any ACE test. 

Specifically, applicants seeking to 

establish importer or broker accounts so 

as to access the ACE Portal, or to 

participate in any ACE test, are no 

longer required to provide a statement 

certifying participation in the Customs 

Trade Partnership Against Terrorism 

(C–TPAT). Participation in C–TPAT has 

never been a requirement to establish a 

carrier account.

EFFECTIVE DATES: The elimination of the 

C–TPAT requirement to establish an 

account or participate in any ACE test 

is effective immediately.

FOR FURTHER INFORMATION CONTACT: Mr. 

Michael Maricich via e-mail at 

Michael.Maricich@dhs.gov, or by 

telephone at (703) 668–2406.

SUPPLEMENTARY INFORMATION: 

Background 

On May 1, 2002, CBP published a 

General Notice in the Federal Register

(67 FR 21800) announcing a plan to 

conduct a National Customs 

Automation Program (NCAP) test of the 

first phase of the Automated 

Commercial Environment. In this 

notice, CBP stated that it planned to 

select approximately forty importer 

accounts from the list of qualified 

applicants for the initial deployment of 

this test. The notice also stated that 

additional participants may be selected 

throughout the duration of this test. In 

order to be considered as one of the 

initial participants, importers’

applications had to be received by CBP 

by June 1, 2002. Applications had to 

include the importer name, a unique 

importer number, a statement certifying 

participation in C–TPAT, and a 

statement certifying the capability to 

connect to the Internet. 

On June 18, 2002, CBP extended the 

application period for those desiring to 

be one of the initial importer 

participants by publishing a second 

General Notice in the Federal Register

(67 FR 41572). That notice emphasized 

that applications to be an initial 

participant had to be submitted to CBP 

prior to August 1, 2002. Applications 

would be accepted after that date, but 

parties who so applied would be placed 

on a waiting list and considered for 

participation pending expansion of the 

technology. 

On February 4, 2004, CBP published 

a third General Notice in the Federal 

Register (69 FR 5362) announcing the 

next step toward the full electronic 

processing of commercial importations 

in ACE, with a focus on identifying 

authorized importers and brokers to 

participate in the test to implement the 

Periodic Monthly Statement Process. 

The Notice stated that participants in 

this test would benefit by having access 

to operational data through the ACE 

Portal, enjoying the capability of being 

able to interact electronically with CBP, 

and making payments of duties and fees 

on a periodic monthly basis. Customs 

brokers, in order to apply, were required 

to provide names of the initial forty-one 

importers participating in the test by 

whom they had been or will have been 

designated as the authorized broker. In 

order to establish an ACE Broker 

Account, a broker was further required 

to file an application for participation 

which was to include the broker name, 

unique identification number, filer 

code, statement certifying participation 

in C–TPAT, statement certifying the 

capability of connecting to the Internet, 

statement certifying capability of 

making periodic payment via the 

Automated Clearing House (ACH) Credit 

or ACH Debit, and a statement certifying 

capability of filing entry/entry summary 

via Automated Broker Interface (ABI). 

Also on February 4, 2004, CBP 

published a General Notice in the 

Federal Register (69 FR 5360) which 

described the application process to be 

followed in order to establish a truck 

carrier account so as to be eligible to 

participate in the electronic truck 

manifest functionality. C–TPAT 

participation is not required in order to 

establish a truck carrier account. 

On September 8, 2004, CBP published 

a General Notice in the Federal Register

(69 FR 54302), reminding the public 

that importers and their designated 

brokers may still apply to establish 

accounts so as to participate in the 

Periodic Monthly Statement Process. 

The Notice again invited customs 

brokers to participate in the ACE Portal 

test generally. 

C–TPAT Participation No Longer 

Required 

In order to encourage maximum 

participation in ACE and make benefits 

such as periodic monthly payment 

widely available, the application 

process to establish an importer or 

broker account or to participate in any 

ACE test will no longer require that a 

statement certifying C–TPAT 

participation be provided. It is 

important to note that this in no way 

indicates that the support of CBP 

management for the C–TPAT program 

has diminished. C–TPAT participants